These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 29179815)
21. MAPRE2 mutations result in altered human cranial neural crest migration, underlying craniofacial malformations in CSC-KT syndrome. Thues C; Valadas JS; Deaulmerie L; Geens A; Chouhan AK; Duran-Romaña R; Schymkowitz J; Rousseau F; Bartusel M; Rehimi R; Rada-Iglesias A; Verstreken P; Van Esch H Sci Rep; 2021 Mar; 11(1):4976. PubMed ID: 33654163 [TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration. Albino D; Brizzolara A; Moretti S; Falugi C; Mirisola V; Scaruffi P; Di Candia M; Truini M; Coco S; Bonassi S; Tonini GP Int J Dev Biol; 2011; 55(1):65-72. PubMed ID: 21425081 [TBL] [Abstract][Full Text] [Related]
23. Neural crest motility and integrin regulation are distinct in cranial and trunk populations. Strachan LR; Condic ML Dev Biol; 2003 Jul; 259(2):288-302. PubMed ID: 12871702 [TBL] [Abstract][Full Text] [Related]
24. Identification of one novel CHD7 mutation in a patient from China with atypical CHARGE syndrome. Cheng J; Ma D; Wu Y; Luo C; Huang C; Hu P; Zhang J; Jiang T; Xu Z Gene; 2015 Oct; 571(2):298-302. PubMed ID: 26187070 [TBL] [Abstract][Full Text] [Related]
25. Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest cells in the formation of neural crest-derived stem cells. Fujita K; Ogawa R; Kawawaki S; Ito K Mech Dev; 2014 Aug; 133():126-45. PubMed ID: 24836203 [TBL] [Abstract][Full Text] [Related]
26. Modeling human congenital disorders with neural crest developmental defects using patient-derived induced pluripotent stem cells. Okuno H; Okano H Regen Ther; 2021 Dec; 18():275-280. PubMed ID: 34504908 [TBL] [Abstract][Full Text] [Related]
27. Role of Chd7 in zebrafish: a model for CHARGE syndrome. Patten SA; Jacobs-McDaniels NL; Zaouter C; Drapeau P; Albertson RC; Moldovan F PLoS One; 2012; 7(2):e31650. PubMed ID: 22363697 [TBL] [Abstract][Full Text] [Related]
28. CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development. Yao H; Hill SF; Skidmore JM; Sperry ED; Swiderski DL; Sanchez GJ; Bartels CF; Raphael Y; Scacheri PC; Iwase S; Martin DM JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467333 [TBL] [Abstract][Full Text] [Related]
29. Mutation update on the CHD7 gene involved in CHARGE syndrome. Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308 [TBL] [Abstract][Full Text] [Related]
30. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. Bergman JE; Janssen N; Hoefsloot LH; Jongmans MC; Hofstra RM; van Ravenswaaij-Arts CM J Med Genet; 2011 May; 48(5):334-42. PubMed ID: 21378379 [TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular effects of CHD7 in the heart. Corsten-Janssen N; Scambler PJ Am J Med Genet C Semin Med Genet; 2017 Dec; 175(4):487-495. PubMed ID: 29088513 [TBL] [Abstract][Full Text] [Related]
32. Evidence for replicative mechanism in a CHD7 rearrangement in a patient with CHARGE syndrome. Vatta M; Niu Z; Lupski JR; Putnam P; Spoonamore KG; Fang P; Eng CM; Willis AS Am J Med Genet A; 2013 Dec; 161A(12):3182-6. PubMed ID: 23956205 [TBL] [Abstract][Full Text] [Related]
33. CHD7, Oct3/4, Sox2, and Nanog control FoxD3 expression during mouse neural crest-derived stem cell formation. Fujita K; Ogawa R; Ito K FEBS J; 2016 Oct; 283(20):3791-3806. PubMed ID: 27579714 [TBL] [Abstract][Full Text] [Related]
34. Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome. Bélanger C; Bérubé-Simard FA; Leduc E; Bernas G; Campeau PM; Lalani SR; Martin DM; Bielas S; Moccia A; Srivastava A; Silversides DW; Pilon N Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E620-E629. PubMed ID: 29311329 [TBL] [Abstract][Full Text] [Related]
35. TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. Fan X; Masamsetti VP; Sun JQ; Engholm-Keller K; Osteil P; Studdert J; Graham ME; Fossat N; Tam PP Elife; 2021 Feb; 10():. PubMed ID: 33554859 [TBL] [Abstract][Full Text] [Related]
36. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome. Basson MA; van Ravenswaaij-Arts C Trends Genet; 2015 Oct; 31(10):600-611. PubMed ID: 26411921 [TBL] [Abstract][Full Text] [Related]
37. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Lee G; Kim H; Elkabetz Y; Al Shamy G; Panagiotakos G; Barberi T; Tabar V; Studer L Nat Biotechnol; 2007 Dec; 25(12):1468-75. PubMed ID: 18037878 [TBL] [Abstract][Full Text] [Related]
38. The chromatin remodeling protein CHD7, mutated in CHARGE syndrome, is necessary for proper craniofacial and tracheal development. Sperry ED; Hurd EA; Durham MA; Reamer EN; Stein AB; Martin DM Dev Dyn; 2014 Sep; 243(9):1055-66. PubMed ID: 24975120 [TBL] [Abstract][Full Text] [Related]
39. Non-homologous end joining repair mechanism-mediated deletion of CHD7 gene in a patient with typical CHARGE syndrome. Lee SJ; Chae JH; Lee JA; Cho SI; Seo SH; Park H; Seong MW; Park SS Ann Lab Med; 2015 Jan; 35(1):141-5. PubMed ID: 25553296 [TBL] [Abstract][Full Text] [Related]